NCT04015167View on ClinicalTrials.gov

A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

November 10, 2022

Study Completion Date

August 8, 2023

Conditions
Tibial Fractures
Interventions
DEVICE

T2 Alpha Tibia Nailing System

The T2 Alpha Tibia Nailing System is intended for temporary stabilization of bone segments or fragments until bone consolidation has been achieved.

Trial Locations (4)

10016

New York University, New York

22042

Inova Fairfax Medical Campus, Falls Church

45229

UC Health, Cincinnati

56377

St. Cloud Orthopedic Associates, Ltd, Sartell

All Listed Sponsors
lead

Stryker Trauma and Extremities

INDUSTRY

NCT04015167 - A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System | Biotech Hunter | Biotech Hunter